Teva Pharmaceutical Industries' shares are trading higher due to the company's assurance that the ongoing Israel-Hamas conflict will not significantly impact its business and financial performance. This news is directly related to the company and is likely to influence investor sentiment, potentially leading to increased demand for the company's shares in the short term.